Joanne M. Hackett

Joanne Hackett is a highly accomplished entrepreneur, scientist, and strategist, known for her expertise in executing and managing complex business transactions.

Currently serving as the Vice President of Genomic and Precision Medicine at IQVIA, Joanne is responsible for creating a portfolio of external investments and strategic alliances to advance technology, product strategies, and research goals.

Her extensive business development experience spans negotiating, executing, and managing numerous transactions with Pharma, Biotech, academia, and non-profits, involving co-development, licensing, collaborative R&D, and consortia.

In addition to her prowess in deal negotiation and strategic planning, Joanne has a strong background in change management, project management, team building, and communication in multidisciplinary fields such as genomics, tissue engineering, and regenerative medicine.

Joanne's academic journey includes a PhD from the University of New Brunswick, a diploma in University Teaching from the same university, as well as postdoctoral fellowships from prestigious institutions like The Johns Hopkins University, Harvard Medical School, and the University of Ottawa.

Furthermore, Joanne honed her skills in project management and yoga teaching, among other fields, through courses at institutions like Project Management Institute and Ethos.

Throughout her illustrious career, Joanne has held key positions in various organizations, including serving on the board of eLife Sciences Publications, Ltd., and as the Health Executive in Residence at UCL Global Business School for Health.

Her leadership roles have spanned entities like AgeX Therapeutics, Inc., BIOS Health Ltd, and Genomics England, where she served as the Chief Commercial Officer.

Moreover, Joanne has lent her expertise to institutions like the University of Oxford and Pfizer Neusentis, providing strategic insights and guidance.

With a wealth of experience in the healthcare, biotech, and pharmaceutical sectors, Joanne Hackett continues to be a driving force in advancing precision medicine and genomics through her strategic acumen and cross-functional team leadership.